Real-World Assessment of Transcranial Direct Current Stimulation (tDCS) Combined with Sertraline in the Treatment of Depression in Vietnam
Do et al., 2026. Neuropsychiatric Disease and Treatment
This randomized study looked at whether adding tDCS to the antidepressant sertraline improves outcomes for hospital inpatients with major depressive disorder.
- Design: An open-label trial with 140 inpatients, randomized to sertraline alone or sertraline plus tDCS, given as part of routine care.
- Treatment: 10 tDCS sessions over 2 weeks at 2 mA for 20 minutes, with the anode over the left dorsolateral prefrontal cortex.
- Main result: Depression scores improved in both groups, but more in the tDCS group. Patients in the tDCS group were more likely to respond to treatment (odds ratio about 4.3 on the BDI and 6.5 on the HAMD) and had a larger rise in serum serotonin.
CONCLUSION: Adding tDCS to sertraline was linked to better clinical and biological outcomes in routine care. Sham-controlled studies are needed to confirm this.